Multi-center evaluation of the fully automated PCR-based Idylla™ KRAS mutation assay for rapid KRAS mutation status determination on formalin-fixed paraffin-embedded tissue of human colorectal cancer

Multi-center evaluation of the fully automated PCR-based Idylla™ KRAS mutation assay for rapid KRAS mutation status determination on formalin-fixed paraffin-embedded tissue of human colorectal cancer

<p>Since the advent of monoclonal antibodies against epidermal growth factor receptor (EGFR) in colorectal cancer therapy, the determination of RAS mutational status is needed for therapeutic decision-making. Most prevalent in colorectal cancer are <em>KRAS</em> exon 2 mutations (4...

Podrobná bibliografie
Hlavní autoři:	Solassol, J, Vendrell, J, Märkl, B, Haas, C, Bellosillo, B, Montagut, C, Smith, M, O'Sullivan, B, D'Haene, N, Le Mercier, M, Grauslund, M, Melchior, L, Burt, E, Cotter, F, Stieber, D, Schmitt, F, Motta, V, Lauricella, C, Colling, R, Soilleux, E, Fassan, M, Mescoli, C, Collin, C, Pagès, J, Sillekens, P
Médium:	Journal article
Jazyk:	English
Vydáno:	Public Library of Science 2016

Podobné jednotky

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.
Autor: Jérôme Solassol, a další
Vydáno: (2016-01-01)

Spatial heterogeneity of KRAS mutations in colorectal cancers in northern France
Autor: Turpin A, a další
Vydáno: (2019-09-01)

KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature
Autor: Sarah Bouri, a další
Vydáno: (2020-01-01)

KRAS mutations and endometriosis burden of disease
Autor: Natasha L Orr, a další
Vydáno: (2023-07-01)

Clinical Significance of the KRAS Mutation
Autor: Sead Beganovic
Vydáno: (2010-10-01)

P53 and PIK3CA Mutations in KRAS/HER2 Negative Ovarian Intestinal-Type Mucinous Carcinoma Associated with Mature Teratoma
Autor: Sarah Bouri, a další
Vydáno: (2020-01-01)

Mutations in the KRAS gene in ovarian tumors.
Autor: Wiesława Niklińska, a další
Vydáno: (2009-12-01)

KRAS mutation in biliary tract cholangiocarcinoma
Autor: Sora Yasri
Vydáno: (2017-03-01)

The origins and genetic interactions of KRAS mutations are allele- and tissue-specific
Autor: Joshua H. Cook, a další
Vydáno: (2021-03-01)

KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice
Autor: Jasmine C. Wong, a další
Vydáno: (2020-11-01)

Somatic mutation detection and KRAS amplification in testicular germ cell tumors
Autor: Eduardo R. M. Cabral, a další
Vydáno: (2023-03-01)

Codon-specific KRAS mutations predict survival in advanced pancreatic cancer
Autor: A. Boilève, a další
Vydáno: (2024-03-01)

Capturing the primordial Kras mutation initiating urethane carcinogenesis
Autor: Siqi Li, a další
Vydáno: (2020-04-01)

Novel KRAS gene mutations in sporadic colorectal cancer.
Autor: Walid M Naser, a další
Vydáno: (2014-01-01)

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients
Autor: Carlos E. Bacchi, a další
Vydáno: (2012-01-01)

Role of silent mutations in KRAS-mutant tumors
Autor: Jun Lu, a další
Vydáno: (2025-02-01)

Mutational profile of KRAS-positive colorectal cancer
Autor: E. N. Telysheva, a další
Vydáno: (2022-03-01)

Targeting mutated KRAS in the first‐line therapy
Autor: Hideaki Ijichi
Vydáno: (2024-04-01)

Characterization of KRAS Mutational Regression in Oligometastatic Patients
Autor: Alessandro Ottaiano, a další
Vydáno: (2022-07-01)

KRAS and TP53 mutations in colorectal carcinoma
Autor: Al-Kuraya Khawla
Vydáno: (2009-01-01)

Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
Autor: Wiesława Niklińska, a další
Vydáno: (2009-05-01)

KRAS mutation: from undruggable to druggable in cancer
Autor: Lamei Huang, a další
Vydáno: (2021-11-01)

The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts
Autor: Abdurrahman Kadayifci, a další
Vydáno: (2016-03-01)

Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.
Autor: Chih-Chieh Chen, a další
Vydáno: (2013-01-01)

KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways
Autor: Koushik Mondal, a další
Vydáno: (2024-07-01)

Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
Autor: Anna Linehan, a další
Vydáno: (2024-03-01)

Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
Autor: Tereza Vaclova, a další
Vydáno: (2022-02-01)

Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated With Immunotherapy in The Netherlands
Autor: Anneloes L. Noordhof, MD, a další
Vydáno: (2023-09-01)

Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
Autor: Parneet K. Cheema, a další
Vydáno: (2023-07-01)

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib.
Autor: William Pao, a další
Vydáno: (2005-01-01)

Beyond structural bioinformatics for genomics with dynamics characterization of an expanded KRAS mutational landscape
Autor: Brian D. Ratnasinghe, a další
Vydáno: (2023-01-01)

Clinicopathologic features and KRAS mutation incidence of gastric carcinomas
Autor: Didar Gürsoy, a další
Vydáno: (2022-01-01)

KRAS Gene Mutations and Gender Differences in Colorectal Cancer
Autor: Dmitriy I. Vodolazhskiy, a další
Vydáno: (2015-03-01)

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
Autor: Hui ZHANG, a další
Vydáno: (2015-11-01)

IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER
Autor: Renato Morato ZANATTO, a další
Vydáno: (2020-12-01)

Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
Autor: Satoshi Inoue, a další
Vydáno: (2019-12-01)

Diameter of Superior Rectal Vein – CT Predictor of KRAS Mutation in Rectal Carcinoma
Autor: Song C, a další
Vydáno: (2020-10-01)

KRAS mutations in patients with AML: clinical characteristics and not reported mutations using NGS
Autor: Salma Said Ibrahim Elsayed, a další
Vydáno: (2024-12-01)

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
Autor: Abdelrahman Yousef, a další
Vydáno: (2024-02-01)

Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab
Autor: Justine Bellier, a další
Vydáno: (2020-02-01)